SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Spectrum Pharmaceuticals, Inc. Provides Update on Belinostat Registrational Trial for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)